WHO ICTRP trial

A study to evaluate the safety and efficacy of SOT102 as a single drug or in…

EUCTR2021-005873-25-ES · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2021-005873-25-ES
Public title A study to evaluate the safety and efficacy of SOT102 as a single drug or in combination with standard of care treatment, in patients with stomach and pancreas cancer
Scientific title A multicentric phase 1/2 trial to evaluate the safety and efficacy of SOT102 as monotherapy and in combination with standard of care treatment in patients with gastric and pancreatic adenocarcinoma
Primary sponsor SOTIO Biotech a.s.
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries United States;France;Czechia;Belgium;Spain
Conditions Gastric and pancreatic adenocarcinoma MedDRA version: 21.1 Level: LLT Classification code 10066354 Term: Adenocarcinoma of the gastroesophageal junction System Organ Class: 100000004864 MedDRA version: 21.1 Level: LLT Classification code…
Interventions Product Name: SOT102 Product Code: SOT102 Pharmaceutical Form: Solution for infusion INN or Proposed INN: antibody-drug conjugate of an anti-CLDN18.2 mAb and the cytotoxic drug PNU159682, coupled by a Gly2-EDA linker Current Sponsor code…
Registration date Jan 17, 2022
Target size 269
Secondary IDs SN201;157062
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations